The Door That Chemistry Opens: Psychedelics and the Neuroscience of Mystical Experience
She had already asked me everything a patient asks about a new cancer diagnosis — staging, prognosis, what comes next. Then, just as her hand was on the door, she turned back. "Doctor," she said quietly, "I read that a single dose of something can take away the fear of dying. Is that real? Could someone like me try it?"
I did not have a prescription to offer her. But the question stayed with me, because it was really two questions folded into one: a question about a molecule, and a question about what waits on the other side of fear. Neuroscience has begun to answer the first. The second is older than any laboratory.
In 2016, research teams at Johns Hopkins and New York University published, almost simultaneously, trials in which patients facing life-threatening cancer were given a single carefully supervised dose of psilocybin, the active compound in certain mushrooms. The results were striking: depression and anxiety dropped sharply, the dread of death eased, and a renewed sense of meaning and peace persisted in many patients six months later. What mattered was not the size of the dose but the depth of what researchers cautiously called a "mystical-type experience."
Brain imaging offers a partial explanation. Psilocybin binds to serotonin 2A receptors, which are densely packed in the cortical regions that make up the default mode network — the circuit that lights up not when we are doing something, but when we are doing nothing at all. It is the network that replays old regrets, rehearses tomorrow's worries, and narrates the story we call "me." In 2012, Robin Carhart-Harris and colleagues found that psilocybin actually quiets this network, loosening its internal connections. As the self-narrating circuit goes softer, people report a thinning of the boundary between self and world — what researchers term "ego dissolution." And curiously, when that inner radio finally goes quiet, people describe not terror but a profound peace. Around the same time, MDMA-assisted therapy for PTSD was completing its own late-stage trials, working by a different chemical door but toward a similar end: loosening a fear circuit that has been locked rigid so that an old wound, long unbearable to face, can finally be revisited and laid down.
A doorbell can be traced wire for wire — the current, the switch, the ring. But who is standing on the other side of the door is not written anywhere in that circuit.
Here is where the reductive temptation grows strongest. It is tempting to say that a mystical experience is nothing more than a serotonin receptor firing. But that sentence only tells us a door opened. It says nothing about what, or who, was met once someone stepped through it. Brain imaging can show us the hinge turning. It cannot see into the room. A century ago, William James drew a distinction worth keeping close here: the origin of a religious experience and its fruit are two separate questions. That an experience arose from a chemical does not automatically cancel whatever fruit it bears in a life — less fear, more love, a softened heart. But neither does intensity guarantee that the fruit is genuine. A blazing experience is not proof of encounter any more than a quiet one is proof of its absence.
This is precisely the distinction the Catholic tradition has always insisted on making, and it never rested its judgment on intensity. Teresa of Ávila questioned the source of every vision and consolation she received. Ignatius of Loyola built an entire discipline — the discernment of spirits — around a single patient question: not how dazzling was the experience, but where does it lead a person? Toward more humility, more freedom, more love — or away from them? The tradition has never mistaken an altered state, however produced, for union with God. Grace is not summoned on demand, and it does not arrive in a capsule. And yet the same tradition has long known that grace travels through matter — bread and wine, water and oil. Faith has never been a purely spiritual transaction; it has always passed through what can be touched, tasted, and held. We do something similar even in ordinary love: a feeling with no substance of its own becomes real to another person through a letter, a warm meal, a hand held in silence. If love can travel through matter to reach someone, the discovery that a molecule can open a door in the mind is not a threat to faith so much as a strange new footnote to an old intuition. Opening a door is not the same thing as meeting whoever is waiting behind it.
As a neurologist, I prescribe none of this — these treatments are not yet part of clinical practice where I work. But patients still raise the question, almost always near the end of a visit, after the real business has been finished and their hand is already on the door. I used to answer as though it were only a request for medical information, walking carefully through trial phases and limitations. It took me longer than I would like to admit to notice that people did not leave the room after I finished explaining. The weight of the question was never really in the pharmacology. Now, when it comes up, I set the science aside for a moment and ask instead how their nights have been. That is usually where the real conversation begins. One patient, newly diagnosed with thyroid cancer, answered questions about her scan results for a long while before saying, almost as an afterthought, that she could not sleep anymore. What passed between us in that moment was not a drug's name. It was one person setting down, for a moment, a fear she had been carrying alone.
So I tell my patients honestly: the trials are real, but this is not yet a treatment we can offer, and no one should attempt it unsupervised. And then I add the one thing my instruments cannot decide for them — whether an experience that eases someone's fear was an event in a serotonin circuit or an encounter with something beyond it. The origin, science will keep clarifying. The fruit belongs to each life. And what to call that fruit is a matter settled only between a person and the One who made them.
These essays are personal reflection at the intersection of neuroscience and faith — not medical advice.
댓글
댓글 쓰기